Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials
We report herein the synthesis and biological testing of several glycosylated derivatives of some fluoroquinolone antibiotics. In particular, we have prepared several glycosylated derivatives of ciprofloxacin (2) in which the carbohydrate units are linked to the free secondary amine of the piperazin...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1999-09, Vol.42 (19), p.3899-3909 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3909 |
---|---|
container_issue | 19 |
container_start_page | 3899 |
container_title | Journal of medicinal chemistry |
container_volume | 42 |
creator | Jung, Michael E Yang, Eric C Vu, Binh T Kiankarimi, Mehrak Spyrou, Emmanouil Kaunitz, Jon |
description | We report herein the synthesis and biological testing of several glycosylated derivatives of some fluoroquinolone antibiotics. In particular, we have prepared several glycosylated derivatives of ciprofloxacin (2) in which the carbohydrate units are linked to the free secondary amine of the piperazine unit by: (a) no linker (e.g., a glycosylamine), (b) a β-oxyethyl linker, and (c) a γ-oxypropyl linker. Both glucose and galactose were used as carbohydrates so that six compounds of this type were prepared, e.g., no linker 4a,b, oxyethyl linker 5a,b, and oxypropyl linker 6a,b. In addition the aryl glycosides of glucose and galactose (7a,b) were prepared from the active 1-(4-hydroxyphenyl)fluoroquinolone (3.) The syntheses of the glycosylamines 4a,b involved the direct condensation of glucose and galactose with the hydrochloride salt of ciprofloxacin (2). For the oxyalkyl-linked compounds, we first prepared the peracetylated ω-bromoalkyl glycopyranosides 14a,b and 15a,b and then coupled them to the allyl ester of ciprofloxacin (11) to give, after saponification to remove all of the esters, the desired fluoroquinolone carbohydrates 5a,b and 6a,b. The final series was prepared from 2,4,5-trifluorobenzoyl chloride (22) which gave 3 in four precedented steps. Coupling of 3 with the peracetylated glucosyl and galactosyl halides 12a,b and 26 afforded, after saponification, the desired aryl glycosides 7a,b. Six of these derivatives of ciprofloxacin4a,b, 5a,b, and 6a,bwere subjected to microbiological screening. Of the six, compound 6a showed the highest activity. Since 6a would give the hydroxypropyl-substituted ciprofloxacin on hydrolysis and its activity is ∼4−8 times less than that of ciprofloxacin (2), this implies that compound 6a is probably being actively transported. Thus preliminary results suggest that some of the compounds are stable in culture conditions and may be differentially transported by multiple resistant organisms. In some cases, the addition of a linker and a carbohydrate to ciprofloxacin lessens, but does not eliminate, antimicrobial activity. |
doi_str_mv | 10.1021/jm990015b |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70787852</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70787852</sourcerecordid><originalsourceid>FETCH-LOGICAL-a378t-743e12f6d2185bcc65ec8af780333608535c0ee876371ded9fe9b990e75173063</originalsourceid><addsrcrecordid>eNpt0UFv0zAUB_AIgVgZHPgCyAdA4hCw4zp2jt1gA6lsk1ombpbjvLTuErvYDlo-CN8Xl1SDA5Kld_DPT8__l2UvCX5PcEE-7Pqqwpiw-lE2I6zA-Vzg-eNshnFR5EVZ0JPsWQg7jDElBX2anRDMsJhTMct-XXajdmHsVDTOIteii25w3v0YjHWdsxBQ3Ho3bLboo_GgI1K2Qdf34wasitCgG9eNPcTt2IEFtDT2Tm3SI5UOWg0b5fOv0Jg_dKGj-Qlo7ZUNe-cjWo0hQo9a59HCRtMb7V1tVBeeZ0_aVODFsZ5m3y4-rc8_58vryy_ni2WuKBcx53MKpGjLpiCC1VqXDLRQLReYUlpiwSjTGEDwknLSQFO1UNUpKuCMcIpLepq9nfruDz-GEGVvgoauUxbcECTHXHDBigTfTTBNGIKHVu696ZUfJcHysAP5sINkXx2bDnUPzT9yCj2B10egglZdm_LQJvx1Fa8Yw4nlEzMppfuHa-XvZMkpZ3J9s5JXt9_J2S27kgf_ZvJKB7lzg7cpuv_M9xtQCawv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70787852</pqid></control><display><type>article</type><title>Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials</title><source>ACS Publications</source><source>MEDLINE</source><creator>Jung, Michael E ; Yang, Eric C ; Vu, Binh T ; Kiankarimi, Mehrak ; Spyrou, Emmanouil ; Kaunitz, Jon</creator><creatorcontrib>Jung, Michael E ; Yang, Eric C ; Vu, Binh T ; Kiankarimi, Mehrak ; Spyrou, Emmanouil ; Kaunitz, Jon</creatorcontrib><description>We report herein the synthesis and biological testing of several glycosylated derivatives of some fluoroquinolone antibiotics. In particular, we have prepared several glycosylated derivatives of ciprofloxacin (2) in which the carbohydrate units are linked to the free secondary amine of the piperazine unit by: (a) no linker (e.g., a glycosylamine), (b) a β-oxyethyl linker, and (c) a γ-oxypropyl linker. Both glucose and galactose were used as carbohydrates so that six compounds of this type were prepared, e.g., no linker 4a,b, oxyethyl linker 5a,b, and oxypropyl linker 6a,b. In addition the aryl glycosides of glucose and galactose (7a,b) were prepared from the active 1-(4-hydroxyphenyl)fluoroquinolone (3.) The syntheses of the glycosylamines 4a,b involved the direct condensation of glucose and galactose with the hydrochloride salt of ciprofloxacin (2). For the oxyalkyl-linked compounds, we first prepared the peracetylated ω-bromoalkyl glycopyranosides 14a,b and 15a,b and then coupled them to the allyl ester of ciprofloxacin (11) to give, after saponification to remove all of the esters, the desired fluoroquinolone carbohydrates 5a,b and 6a,b. The final series was prepared from 2,4,5-trifluorobenzoyl chloride (22) which gave 3 in four precedented steps. Coupling of 3 with the peracetylated glucosyl and galactosyl halides 12a,b and 26 afforded, after saponification, the desired aryl glycosides 7a,b. Six of these derivatives of ciprofloxacin4a,b, 5a,b, and 6a,bwere subjected to microbiological screening. Of the six, compound 6a showed the highest activity. Since 6a would give the hydroxypropyl-substituted ciprofloxacin on hydrolysis and its activity is ∼4−8 times less than that of ciprofloxacin (2), this implies that compound 6a is probably being actively transported. Thus preliminary results suggest that some of the compounds are stable in culture conditions and may be differentially transported by multiple resistant organisms. In some cases, the addition of a linker and a carbohydrate to ciprofloxacin lessens, but does not eliminate, antimicrobial activity.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm990015b</identifier><identifier>PMID: 10508438</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Anti-Infective Agents - metabolism ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Biological Transport, Active ; Ciprofloxacin - analogs & derivatives ; Ciprofloxacin - metabolism ; Galactose - metabolism ; Glucose - metabolism ; Glycosylation ; Half-Life ; Magnetic Resonance Spectroscopy ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Piperazines</subject><ispartof>Journal of medicinal chemistry, 1999-09, Vol.42 (19), p.3899-3909</ispartof><rights>Copyright © 1999 American Chemical Society</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a378t-743e12f6d2185bcc65ec8af780333608535c0ee876371ded9fe9b990e75173063</citedby><cites>FETCH-LOGICAL-a378t-743e12f6d2185bcc65ec8af780333608535c0ee876371ded9fe9b990e75173063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm990015b$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm990015b$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1979550$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10508438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Michael E</creatorcontrib><creatorcontrib>Yang, Eric C</creatorcontrib><creatorcontrib>Vu, Binh T</creatorcontrib><creatorcontrib>Kiankarimi, Mehrak</creatorcontrib><creatorcontrib>Spyrou, Emmanouil</creatorcontrib><creatorcontrib>Kaunitz, Jon</creatorcontrib><title>Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report herein the synthesis and biological testing of several glycosylated derivatives of some fluoroquinolone antibiotics. In particular, we have prepared several glycosylated derivatives of ciprofloxacin (2) in which the carbohydrate units are linked to the free secondary amine of the piperazine unit by: (a) no linker (e.g., a glycosylamine), (b) a β-oxyethyl linker, and (c) a γ-oxypropyl linker. Both glucose and galactose were used as carbohydrates so that six compounds of this type were prepared, e.g., no linker 4a,b, oxyethyl linker 5a,b, and oxypropyl linker 6a,b. In addition the aryl glycosides of glucose and galactose (7a,b) were prepared from the active 1-(4-hydroxyphenyl)fluoroquinolone (3.) The syntheses of the glycosylamines 4a,b involved the direct condensation of glucose and galactose with the hydrochloride salt of ciprofloxacin (2). For the oxyalkyl-linked compounds, we first prepared the peracetylated ω-bromoalkyl glycopyranosides 14a,b and 15a,b and then coupled them to the allyl ester of ciprofloxacin (11) to give, after saponification to remove all of the esters, the desired fluoroquinolone carbohydrates 5a,b and 6a,b. The final series was prepared from 2,4,5-trifluorobenzoyl chloride (22) which gave 3 in four precedented steps. Coupling of 3 with the peracetylated glucosyl and galactosyl halides 12a,b and 26 afforded, after saponification, the desired aryl glycosides 7a,b. Six of these derivatives of ciprofloxacin4a,b, 5a,b, and 6a,bwere subjected to microbiological screening. Of the six, compound 6a showed the highest activity. Since 6a would give the hydroxypropyl-substituted ciprofloxacin on hydrolysis and its activity is ∼4−8 times less than that of ciprofloxacin (2), this implies that compound 6a is probably being actively transported. Thus preliminary results suggest that some of the compounds are stable in culture conditions and may be differentially transported by multiple resistant organisms. In some cases, the addition of a linker and a carbohydrate to ciprofloxacin lessens, but does not eliminate, antimicrobial activity.</description><subject>Anti-Infective Agents - metabolism</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Biological Transport, Active</subject><subject>Ciprofloxacin - analogs & derivatives</subject><subject>Ciprofloxacin - metabolism</subject><subject>Galactose - metabolism</subject><subject>Glucose - metabolism</subject><subject>Glycosylation</subject><subject>Half-Life</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0UFv0zAUB_AIgVgZHPgCyAdA4hCw4zp2jt1gA6lsk1ombpbjvLTuErvYDlo-CN8Xl1SDA5Kld_DPT8__l2UvCX5PcEE-7Pqqwpiw-lE2I6zA-Vzg-eNshnFR5EVZ0JPsWQg7jDElBX2anRDMsJhTMct-XXajdmHsVDTOIteii25w3v0YjHWdsxBQ3Ho3bLboo_GgI1K2Qdf34wasitCgG9eNPcTt2IEFtDT2Tm3SI5UOWg0b5fOv0Jg_dKGj-Qlo7ZUNe-cjWo0hQo9a59HCRtMb7V1tVBeeZ0_aVODFsZ5m3y4-rc8_58vryy_ni2WuKBcx53MKpGjLpiCC1VqXDLRQLReYUlpiwSjTGEDwknLSQFO1UNUpKuCMcIpLepq9nfruDz-GEGVvgoauUxbcECTHXHDBigTfTTBNGIKHVu696ZUfJcHysAP5sINkXx2bDnUPzT9yCj2B10egglZdm_LQJvx1Fa8Yw4nlEzMppfuHa-XvZMkpZ3J9s5JXt9_J2S27kgf_ZvJKB7lzg7cpuv_M9xtQCawv</recordid><startdate>19990923</startdate><enddate>19990923</enddate><creator>Jung, Michael E</creator><creator>Yang, Eric C</creator><creator>Vu, Binh T</creator><creator>Kiankarimi, Mehrak</creator><creator>Spyrou, Emmanouil</creator><creator>Kaunitz, Jon</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990923</creationdate><title>Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials</title><author>Jung, Michael E ; Yang, Eric C ; Vu, Binh T ; Kiankarimi, Mehrak ; Spyrou, Emmanouil ; Kaunitz, Jon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a378t-743e12f6d2185bcc65ec8af780333608535c0ee876371ded9fe9b990e75173063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anti-Infective Agents - metabolism</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Biological Transport, Active</topic><topic>Ciprofloxacin - analogs & derivatives</topic><topic>Ciprofloxacin - metabolism</topic><topic>Galactose - metabolism</topic><topic>Glucose - metabolism</topic><topic>Glycosylation</topic><topic>Half-Life</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Michael E</creatorcontrib><creatorcontrib>Yang, Eric C</creatorcontrib><creatorcontrib>Vu, Binh T</creatorcontrib><creatorcontrib>Kiankarimi, Mehrak</creatorcontrib><creatorcontrib>Spyrou, Emmanouil</creatorcontrib><creatorcontrib>Kaunitz, Jon</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Michael E</au><au>Yang, Eric C</au><au>Vu, Binh T</au><au>Kiankarimi, Mehrak</au><au>Spyrou, Emmanouil</au><au>Kaunitz, Jon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1999-09-23</date><risdate>1999</risdate><volume>42</volume><issue>19</issue><spage>3899</spage><epage>3909</epage><pages>3899-3909</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>We report herein the synthesis and biological testing of several glycosylated derivatives of some fluoroquinolone antibiotics. In particular, we have prepared several glycosylated derivatives of ciprofloxacin (2) in which the carbohydrate units are linked to the free secondary amine of the piperazine unit by: (a) no linker (e.g., a glycosylamine), (b) a β-oxyethyl linker, and (c) a γ-oxypropyl linker. Both glucose and galactose were used as carbohydrates so that six compounds of this type were prepared, e.g., no linker 4a,b, oxyethyl linker 5a,b, and oxypropyl linker 6a,b. In addition the aryl glycosides of glucose and galactose (7a,b) were prepared from the active 1-(4-hydroxyphenyl)fluoroquinolone (3.) The syntheses of the glycosylamines 4a,b involved the direct condensation of glucose and galactose with the hydrochloride salt of ciprofloxacin (2). For the oxyalkyl-linked compounds, we first prepared the peracetylated ω-bromoalkyl glycopyranosides 14a,b and 15a,b and then coupled them to the allyl ester of ciprofloxacin (11) to give, after saponification to remove all of the esters, the desired fluoroquinolone carbohydrates 5a,b and 6a,b. The final series was prepared from 2,4,5-trifluorobenzoyl chloride (22) which gave 3 in four precedented steps. Coupling of 3 with the peracetylated glucosyl and galactosyl halides 12a,b and 26 afforded, after saponification, the desired aryl glycosides 7a,b. Six of these derivatives of ciprofloxacin4a,b, 5a,b, and 6a,bwere subjected to microbiological screening. Of the six, compound 6a showed the highest activity. Since 6a would give the hydroxypropyl-substituted ciprofloxacin on hydrolysis and its activity is ∼4−8 times less than that of ciprofloxacin (2), this implies that compound 6a is probably being actively transported. Thus preliminary results suggest that some of the compounds are stable in culture conditions and may be differentially transported by multiple resistant organisms. In some cases, the addition of a linker and a carbohydrate to ciprofloxacin lessens, but does not eliminate, antimicrobial activity.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>10508438</pmid><doi>10.1021/jm990015b</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1999-09, Vol.42 (19), p.3899-3909 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_70787852 |
source | ACS Publications; MEDLINE |
subjects | Anti-Infective Agents - metabolism Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Biological Transport, Active Ciprofloxacin - analogs & derivatives Ciprofloxacin - metabolism Galactose - metabolism Glucose - metabolism Glycosylation Half-Life Magnetic Resonance Spectroscopy Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Piperazines |
title | Glycosylation of Fluoroquinolones through Direct and Oxygenated Polymethylene Linkages as a Sugar-Mediated Active Transport System for Antimicrobials |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T19%3A43%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycosylation%20of%20Fluoroquinolones%20through%20Direct%20and%20Oxygenated%20Polymethylene%20Linkages%20as%20a%20Sugar-Mediated%20Active%20Transport%20System%20for%20Antimicrobials&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jung,%20Michael%20E&rft.date=1999-09-23&rft.volume=42&rft.issue=19&rft.spage=3899&rft.epage=3909&rft.pages=3899-3909&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm990015b&rft_dat=%3Cproquest_cross%3E70787852%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70787852&rft_id=info:pmid/10508438&rfr_iscdi=true |